Skip to content

Manicaland VMMC Uptake Through Behavioural Incentives Trial

Improving Risk Perception and Uptake of Voluntary Medical Male Circumcision (VMMC) With Education Sessions and Conditional Behavioural Incentives

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03565588
Enrollment
1028
Registered
2018-06-21
Start date
2018-07-07
Completion date
2021-01-30
Last updated
2023-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Keywords

Voluntary medical male circumcision, HIV prevention, Risk perception

Brief summary

Primary Objective The purpose of this study is to evaluate the impact of an interactive VMMC education session offered by a circumcised health worker and contribution to transport costs for accessing VMMC along with either (1) conditional economic compensation for wages or (2) lottery-based economic incentives on the uptake of VMMC. Hypothesis VMMC education session offered by a role model - a young male health worker who has been previously benefited from VMMC services in this community - addressing risks of HIV infection, benefits of VMMC, and the fear of pain associated with VMMC, with/without a conditional fixed or lottery-based financial incentives off-setting present-biased preferences, will improve risk perception and increase uptake of VMMC in HIV-negative young men. Study outcomes The primary outcomes for the study will be risk perception measured in a follow-up survey at 6 months and proportion of men taking up VMMC within 6 months measured through self-reports and matched to program records.

Interventions

BEHAVIORALEducation session with fixed incentive

All participants will receive an education session on the risk of HIV infection and benefits from medical male circumcision. The sessions will be implemented by trained male healthcare workers who have undergone VMMC. All participants will receive contributions towards transport costs to access medical male circumcision at participating clinics. On completing VMMC, participants assigned to receive fixed incentives will receive payment through mobile payments. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures.

BEHAVIORALEducation session with lottery incentive

All participants will receive an education session on the risk of HIV infection and benefits from medical male circumcision. The sessions will be implemented by trained male healthcare workers who have undergone VMMC. All participants will receive contributions towards transport costs to access medical male circumcision at participating clinics. On completing VMMC, participants will participate in a lottery with prizes equivalent in expected value to the fixed incentives. In two sites a community-led intervention will also be implemented to address social obstacles and to increase support from peers, families and social structures.

Sponsors

Biomedical Research and Training Institute, Zimbabwe
CollaboratorOTHER
University of Copenhagen
CollaboratorOTHER
London School of Economics and Political Science
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH
Simon Gregson
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
15 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* Men * Age 15-29 years

Exclusion criteria

* Participants testing HIV-positive at baseline * Self-reporting have already undergone circumcision

Design outcomes

Primary

MeasureTime frameDescription
Uptake of voluntary medical male circumcision (VMMC)6 monthsProportion of men taking up VMMC within 6 months measured through self-reports and matched to programme records

Secondary

MeasureTime frameDescription
Changes in perception of risk of HIV6 monthsRisk perception will be measured in a follow-up survey at 6 months

Countries

Zimbabwe

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026